FFA
GSK icon

Farther Finance Advisors’s GSK GSK Stock Holding History

Farther Finance Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.96M Buy
40,621
+5,591
+16% +$285K 0.01% 789
2026
Q2 		$1.84M Buy
35,030
+2,201
+7% +$116K 0.01% 790
2026
Q1 		$1.84M Buy
32,829
+3,300
+11% +$179K 0.02% 688
2025
Q4 		$1.45M Buy
29,529
+17,553
+147% +$819K 0.02% 718
2025
Q3 		$517K Buy
11,976
+5,053
+73% +$197K 0.01% 1052
2025
Q2 		$266K Buy
6,923
+838
+14% +$32K 0.01% 1246
2025
Q1 		$230K Buy
6,085
+2,030
+50% +$74.3K 0.01% 1172
2024
Q4 		$137K Sell
4,055
-1,530
-27% -$55.1K 0.01% 1170
2024
Q3 		$228K Sell
5,585
-472
-8% -$19.3K 0.01% 942
2024
Q2 		$232K Buy
6,057
+2,081
+52% +$87.5K 0.01% 780
2024
Q1 		$169K Buy
3,976
+123
+3% +$5.07K 0.01% 744
2023
Q4 		$143K Buy
3,853
+2,037
+112% +$73.1K 0.01% 674
2023
Q3 		$65.8K Buy
1,816
+461
+34% +$16.4K 0.01% 691
2023
Q2 		$48.3K Sell
1,355
-30
-2% -$1.08K 0.01% 684
2023
Q1 		$49.3K Buy
1,385
+1,050
+313% +$36.7K 0.01% 603
2022
Q4 		$11.8K Buy
+335
New +$11.2K ﹤0.01% 893

Other funds holding GSK

KFP
Keystone Financial Planning Cleveland, Ohio $404M AUM 16.77% 1-Year Est. Return
BE
Bonness Enterprises Washington, District of Columbia $307M AUM 22.88% 1-Year Est. Return
PC
Parrish Capital Kennesaw, Georgia $103M AUM 35.11% 1-Year Est. Return
IRC
Investors Research Corp Atlanta, Georgia $569M AUM 15.41% 1-Year Est. Return
BCM
Boltwood Capital Management Walnut Creek, California $443M AUM 17.72% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
CPBTD
Central Pacific Bank - Trust Division Honolulu, Hawaii $952M AUM 25.15% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
RT
Rockland Trust Hanover, Massachusetts $2.61B AUM 14.26% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return

Farther Finance Advisors's GSK Position: Q3 2026 in Review

Farther Finance Advisors increased its GSK (GSK) stake by 16% in Q3 2026, buying an estimated $285K and bringing the position to 40,621 shares worth $1.96M. The position accounts for 0.01% of the portfolio, ranked #789.

Farther Finance Advisors first reported a position in GSK in Q4 2022 and has held it in 16 quarters since. 31 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • Farther Finance Advisors held 40,621 shares of GSK worth $1.96M as of Q3 2026.
  • Farther Finance Advisors bought 5,591 GSK shares in Q3 2026, an estimated $285K.
  • GSK made up 0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #789 holding.
  • Farther Finance Advisors first reported a position in GSK in Q4 2022 and has held it in 16 quarters since.
  • 31 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.